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Background: Excessive sodium consumption is one of the leading dietary risk factors for non-communicable
diseases, including cardiovascular disease (CVD), mediated by high blood pressure. Brazil has implemented
voluntary sodium reduction targets with food industries since 2011. This study aimed to analyse the potential
health and economic impact of these sodium reduction targets in Brazil from 2013 to 2032.
Methods: We developed a microsimulation of a close-to-reality synthetic population (IMPACTNCD-BR) to evaluate the
potential health benefits of setting voluntary upper limits for sodium content as part of the Brazilian government
strategy. The model estimates CVD deaths and cases prevented or postponed, and disease treatment costs. Model
inputs were informed by the 2013 National Health Survey, the 2008–2009 Household Budget Survey, and high-
quality meta-analyses, assuming that all individuals were exposed to the policy proportionally to their sodium
intake from processed food. Costs included costs of the National Health System on CVD treatment and informal
care costs. The primary outcome measures of the model are cardiovascular disease cases and deaths prevented or
postponed over 20 years (2013–2032), stratified by age and sex.
Results: The study found that the application of the Brazilian voluntary sodium targets for packaged foods
between 2013 and 2032 could prevent or postpone approximately 110,000 CVD cases (95% uncertainty intervals
(UI): 28,000 to 260,000) among men and 70,000 cases among women (95% UI: 16,000 to 170,000), and also prevent
or postpone approximately 2600 CVD deaths (95% UI: − 1000 to 11,000), 55% in men. The policy could also
produce a net cost saving of approximately US$ 220 million (95% UI: US$ 54 to 520 million) in medical costs to the
Brazilian National Health System for the treatment of CHD and stroke and save approximately US$ 71 million (95%
UI: US$ 17 to170 million) in informal costs.
Conclusion: Brazilian voluntary sodium targets could generate substantial health and economic impacts. The
reduction in sodium intake that was likely achieved from the voluntary targets indicates that sodium reduction in
Brazil must go further and faster to achieve the national and World Health Organization goals for sodium intake.
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Non-communicable diseases (NCDs) are a global health
problem, and unhealthy diets are among its leading
drivers. Among dietary risk factors, high sodium intake
was the leading cause of morbidity and mortality
worldwide, accounting for some 3 million deaths and 70
million disability-adjusted life-years (DALYs) [1]. In
Brazil, NCDs are responsible for 75% of all deaths, and
cardiovascular disease (CVD) is the most frequent cause
of death among NCDs [2]. CVD represents the most
significant disease burden attributable to high sodium
intake, and much of this risk is mediated through blood
pressure increase [3].
The average daily sodium consumption in Brazil is ap-
proximately double the World Health Organization
(WHO) [4] recommended maximum limit of 2g [5].
Thus, over 27,000 deaths from coronary heart disease
(CHD) and stroke could be prevented or postponed
every year if Brazilians consumed, on average, less than
2 g/day sodium [6]. However, unlike many high-income
countries with “Western” type diets, only about 35% of
Brazilians’ dietary sodium comes from industrialised
foods and salt-based condiments, whereas over 55%
comes from added table salt [7–9]. Sodium reduction
policies in Brazil have therefore incorporated a set of
strategies. These include health education campaigns
targeted to the table salt added to foods and meals [10],
and since 2011, food reformulation strategies aimed at
reducing the sodium content of processed and ultra-
processed products, including condiments, through vol-
untary upper limits for sodium content in priority food
categories [11]. From 2011 to 2017, all food categories
have reduced their upper limits of sodium and most
have reduced their average sodium content, from 8 to
34% [12].
The objective of this study was to quantify the poten-
tial health and economic impacts of voluntary sodium
reformulation in Brazil.
Methods
We have developed IMPACT NCD-BR, a new microsimu-
lation for Brazil using available local data, building on
our previous experience in sodium modelling [13–16].
We used IMPACTNCD-BR to assess the potential health
and economic effects of the voluntary targets for sodium
content in processed foods in Brazil over 20 years
(2013–2032).
We simulated the long-term impact of reducing the
sodium content of processed and ultra-processed foods
through the national voluntary targets from 2013 to
2017, compared to a “no intervention” baseline scenario.
We assumed that sodium reduction in foods was
achieved from 2013 through 2017, that only industries
officially committed to the voluntary targets wouldreduce the sodium content of their products (corre-
sponding to 70% of the Brazilian market share), and that
the sodium content and target compliance by industries
from 2017 onwards [12] would not change. We further
assumed that, given the extent of the reformulation, all
individuals were exposed to the policy proportionally to
their sodium intake from processed food.
The IMPACTNCD-BR model
IMPACTNCD-BR is a discrete-time stochastic, dynamic,
microsimulation model based on the simulated adult life
course of a close-to-reality open cohort of synthetic indi-
viduals under different policy scenarios, considering the
population heterogeneity and the lag times between ex-
posures and outcomes. The data sources to the model
are presented in Table 1, and the model inputs, struc-
ture, and key assumptions are detailed in Supplementary
Materials Appendix.
The model is designed first to run the no intervention
scenario, simulating the life courses of the synthetic indi-
viduals and recording sodium consumption, systolic
blood pressure, first cardiovascular episode, and death
(from CVD or any other cause). Then, it simulates the
life courses of the same synthetic population under the
intervention scenario (in this case, food reformulation
through the national voluntary sodium targets) and re-
cords its outcomes.
The close-to-reality population built in the model mir-
rors the Brazilian national population structure by age
and sex [18]. It includes data from the National Health
Survey (Pesquisa Nacional de Saúde—PNS 2013) [22]
and the National Household Budget Survey (Pesquisa de
Orçamentos Familiares—POF 2008–2009) [20, 21] regard-
ing sodium and systolic blood pressure (SBP) exposure.
Microsimulation model structure
Figure 1 shows a simplified structure of the
IMPACTNCD-BR model. The model tracks individual-
level sodium consumption, considering the different
sources of dietary sodium, its impact on SBP, and the
consequent risk of developing CHD, stroke, and death
from these or any other cause. IMPACTNCD-BR is cali-
brated to forecasts of CHD, stroke, and any-other-cause
mortality for the whole Brazilian population from 2013
to 2032. The results are presented for adults aged 30 to
79 years within the simulation horizon of 20 years.
For this, the model draws the traits of the synthetic in-
dividuals from conditional distributions, projects the so-
dium intake into the future, and uses the projections to
evolve the traits of the synthetic individuals over time.
We used PNS 2013 for the SBP projections (assuming
SBP remains constant over time for all age and sex
groups) and POF 2008–2009 for the sodium intake pro-
jections [20–22].
Table 1 IMPACTNCD-BR data sources
Parameter Outcome Details Comments Source
Population size
estimates
Population Brazilian Institute of
Geography and Statistics
(IBGE)





Population 2010–2060 Brazil population
projections produced by IBGE
Stratified by year, age and sex Brazilian Institute of
Geography and
Statistics (IBGE) [18]
Mortality Deaths from CHD, stroke,
and any other non-
modelled causes
Underlying cause of death
2000–2016
Stratified by year, age and sex National Mortality
Information System
(SIM/SUS) [19]
Sodium exposure Exposure of individuals National Household Budgetary
Survey















Systolic blood pressure Meta-analysis/meta-regression
of 103 trials
Only trials with duration >7 days were
analysed






which no excess risk was
considered to occur
Evidence from ecological
studies, randomised trials, and
meta-analyses of prospective
cohort studies
Intake levels associated with the lowest risk
ranged from 614 to 2391 mg/day; in large,
well-controlled randomised feeding trials, the
lowest tested intake for which blood pressure
reductions were clearly documented was
1500 mg/day




CHD and stroke incidence
(ICD-10: I20–I25 and I60–
I69)
Pooled analysis of 2 individual-
level meta-analyses
Stratified by age and sex; adjusted for
regression dilution and total blood
cholesterol and, where available, lipid
fractions (HDL and non-HDL cholesterol), dia-
betes, weight, alcohol consumption, and
smoking at baseline
Micha et al. [23]
Mortality from any cause
excluding CHD and stroke
Individual-level meta-analysis
of 48 prospective cohort
studies
Adjusted for age, sex, race or ethnicity,
deprivation, smoking, diabetes, inactivity,
alcohol, and obesity





pressure below which no
excess risk was considered
to occur
Evidence from randomised
trials of antihypertensive drugs
and the INTERSALT study
There may be health benefits by lowering
systolic blood pressure down to 110 mm Hg
Singh et al. [25]
Disease costs Public hospitalisation
costs for CHD and stroke
Underlying cause of
hospitalisation (2018)




and informal care and
medication costs for CHD
and stroke
Costs were extrapolated to Brazilian settings Leal et al. [27]
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sodium consumption
Excess dietary sodium consumption has been linked to
an increased risk of CVD [28]. For CVD, the excess risk
appears to be mainly mediated through the deleterious
effect of excess sodium consumption on blood pressure
(BP) [3]. Our methods for evaluating the causality of
sodium reduction on BP and BP reduction on CVD have
been previously described [3].Policy effects
Brazil’s Ministry of Health has set voluntary reduction
targets with food industries, from 2011 to 2017, based
on upper bound sodium concentration targets for 34
food categories [11, 29]. In addition, publicly available
data from the Household Budget Survey (POF 2008–
2009) were used to map these 34 food categories
through household food acquisition [20] and a 24-h
recall dietary questionnaire [21]. These data enabled the
Fig. 1 Simplified structure of the Brazil IMPACT Sodium Policy Model
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policies on every synthetic individual based on their age,
sex, and sodium consumption in the no intervention
baseline scenario. The model then used the estimated
reduction in sodium consumption of the synthetic
individuals to calculate the effect upon their SBP using a
published meta-regression equation [3].
We assumed that reformulation of food products
would adjust sodium content to targets until 2017 and
that this would lead to an immediate change in sodium
intake in synthetic individuals according to the level of
reformulation. We also assumed that the reformulated
products would, after that, sustain their sodium
concentration.
Although changes in sodium intake influence SBP
within weeks [3, 30], we conservatively assumed a
median duration of 5 years from a change in SBP to the
health outcomes of CVD cases and CVD deaths.
Modelling of food composition and sodium intake
changes
We have considered changes in food composition from
the voluntary sodium targets using data from official na-
tional food labelling surveys in 2013 and 2017: the base-
line targets and the most recent documented official
monitoring, respectively [12]. In addition, changes in
sodium intake were modelled using microdata from the
2002–2003 and 2008–2009 Brazilian Household Budget
Survey. We assumed that the average food consumption
and use of table salt in the population remained constant
from 2011 to 2017 and that sodium content was reduced
for the targeted food categories only by industries that
have voluntarily committed to the national sodium targets
(which correspond to a 70% market share in the country).We used the publicly available data from the House-
hold Budget Surveys (POF) of 2002–2003 [31] and
2008–2009 [20] in order to estimate the changes in
sources of dietary sodium (non-industrial and industrial
sources) during the period between both surveys. We
projected the continuity of the replacement of discre-
tionary salt (table salt) by processed and ultra-processed
foods (representing the other sodium sources), assuming
that the replacement would continue at the same rate in
the future.
Model outputs
The model generates the total numbers of relevant
events and reported case-years (CHD and stroke) and
deaths prevented or postponed (CHD or stroke or other)
for each scenario. We present the results for Brazilian
adults aged 30 to 79 years from 2011 to 2032 (simulation
horizon of 20 years), rounded to 2 significant digits. For
simplicity, we used the term “cases prevented or post-
poned” to express case-years prevented or postponed.
Medical costs analyses
The CHD and stroke hospitalisation costs to the
Brazilian National Health System (SUS—Sistema Único
de Saúde) were obtained from the publicly available ta-
bles from the Hospital Information System—SIH-SUS
[26]. There were no readily available Brazil-specific data
for the informal care costs; therefore, we used estimates
for these costs from a study on European Union (EU)
countries [27]. Cost savings to the health system and the
population were estimated considering the CHD and
stroke cases prevented or postponed and the average
costs for a person-year living with these diseases. Costs
were collected in Brazilian Reals (R$) and subsequently
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US$1 = R$3.876, current as of December 31, 2018, as re-
ported by the Central Bank of Brazil, and all costs and
were discounted at a 3% annual rate.Sensitivity analyses and uncertainty analyses
We performed probabilistic sensitivity analyses using a
second-order Monte Carlo approach for estimating the
uncertainty of different model parameters and popula-
tion heterogeneity to be propagated to the outputs [32].
Uncertainty was based on sources of the sampling errors
of baseline sodium intake, baseline SBP, and the relative
risk of CHD and stroke based on SBP, the uncertainties
around the lowest sodium and SBP exposures below
which no excess risk is observed, around the effect of so-
dium on SBP, around the lag between SBP changes and
CVD risk changes, around the true incidence of CHD
and stroke, and the uncertainty of mortality forecasts.
The output distributions produced through the Monte
Carlo approach were summarised by reporting the me-
dians and 95% uncertainty intervals (UIs) using the 2.5%
and 97.5% percentiles of the output distribution.Results
Health-related outcomes
The modelled results suggest that Brazil’s recent volun-
tary sodium reduction policies have led to a 0.1 g/day of
sodium decline in sodium consumption (0.25 g/day salt)
from 2011 to 2017 (Fig. 2). If that 0.1g/day sodium re-
duction continues, it could reduce median SBP from
127.7 mmHg (95% UI: 127.6 to 127.8) in the baseline
scenario to 127.5 mmHg (95% UI: 127.4 to 127.6) in the
reformulation scenario by 2032. Furthermore, it could
prevent or postpone approximately 2500 CVD deaths
(95% UI: −900 to 11,000) and some 180,000 CVD cases
(95% UI: 45,000 to 430,000), as well as 12,000 deathsFig. 2 Median daily sodium consumption by year for the two
scenarios. Note that the y axis does not start from 0from other hypertension-related causes (95% UI: 3600 to
22,000), from 2013 to 2032 (Table 2).
The health benefits of sodium reduction, especially in
reducing CHD, were larger in men than women, reflect-
ing men’s higher sodium consumption and higher CHD
and stroke burden. In total, during the 20-year time
period from 2013 to 2032, the voluntary sodium targets
could prevent or postpone approximately 110,000 CVD
cases (95% UI: 28,000 to 260,000) in men and some
70,000 cases in women (95% UI: 16,000 to 170,000), and
approximately 1400 fewer CVD deaths in men (95% UI:
−500 to 4100) and 1200 fewer deaths in women (−500
to 4800).
Almost two-thirds of the CVD cases and CVD deaths
that would be prevented or postponed by this policy be-
tween 2013 and 2032 would be in people aged 50 to 69
years (Appendix).
Costs of CHD and stroke
From the public healthcare perspective, the voluntary
targets for sodium could result in a net saving of ap-
proximately US$ 290 million (95% UI: US$ 71 to 690
million) in cumulative hospitalisation, primary health,
outpatient, pharmaceutical, and informal care costs, over
the 20 years. Most of the savings would be related to
CHD (~75%) rather than stroke.
The US$ 290 million estimated savings through the
continuity of the voluntary sodium targets would come
from (Table 3):
a) Approximately US$ 220 million savings (95% UI:
US$ 54 to 520 million) related to reduced CHD and
stroke treatment costs to the Brazilian National
Health System.
b) Approximately US$ 70 million (95% UI: US$ 17
to170 million) savings in informal care costs.
Discussion
We have identified potentially large future health and
economic benefits if Brazil were to continue the volun-
tary sodium targets first set in 2011. We used a previ-
ously validated microsimulation approach to create a
close-to-reality synthetic population (IMPACTNCD-BR
model) for the Brazilian population. Our analysis sug-
gests that continuing the voluntary targets could sub-
stantially decrease the CVD burden while also offering
considerable cost savings to the public healthcare system
and individuals.
However, despite the estimated impacts of the imple-
mented voluntary reformulation, mean sodium intake in
Brazil remains well above national targets and WHO
recommendations. Hence, there are substantial health
and economic opportunity costs of inaction, and despite
contributing to the reduction of CVD burden, the
Table 2 Health-related model estimates over a 20-year simulation period, from 2013 to 2032, for Brazilian adults aged over 30 years.
Brackets contain 95% uncertainty intervals
Outcome Men Women Persons As percentage of
total cases/deaths
CHD cases prevented or postponed 67,000 (17,000 to 160,000) 31,000 (6000 to 78,000) 98,000 (23,000 to 240,000) 0.072% (0.030 to 0.15%)
Stroke cases prevented or postponed 45,000 (11,000 to 100,000) 39,000 (10,0 00 to 89,000) 84,000 (22,000 to 190,000) 0.14% (0.068 to 0.23%)
CHD deaths prevented or postponed 700 (−200 to 900) 500 (−200 to 2000) 1200 (−500 to 5000) 0.064% (0.000 to 0.15%)
Stroke deaths prevented or postponed 700 (−200 to 3000) 700 (−200 to 2800) 1400 (−500 to 6000) 0.12% (0.039 to 0.23%)
Non-CVD deaths prevented or
postponed
6900 (2300 to 13,000) 4600 (1400 to 9200) 12,000 (3700 to 22,000) 0.069% (0.041 to 0.11%)
All deaths prevented or postponed 8300 (1800 to 19,000) 5800 (900 to 14,000) 14,000 (2700 to 33,000) 0.073% (0.045 to 0.11%)
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processed foods could be more stringent. Achieving the
WHO recommended targets will require a more effect-
ive comprehensive strategy, including reformulation, to
promote more significant sodium reduction through the
whole spectrum of dietary sodium sources in the Brazilian
population.
When compared to existing regional and global bench-
marks for sodium reduction, Brazil can expect to materi-
alise further benefits by optimising its sodium reduction
strategy [29, 33, 34]. The estimated 0.1-g reduction in
daily sodium consumption from 2011 to 2017 achieved
by Brazil’s voluntary targets has been modest compared
with some other countries. A systematic review of 70
papers concluded that multi-component strategies in-
volving both upstream and downstream interventions
generally achieved the most considerable reductions in
sodium consumption across an entire population, most
notably 1.6g/day in Finland and Japan, 1.2g/day in
Turkey, and 0.52g/day recently in the UK [9]. Mandatory
reformulation alone could achieve a reduction averaging
around 0.58g/day (three separate studies), followed by
voluntary reformulation (−0.32g/day), school interven-
tions (−0.28g/day), short-term dietary advice (−0.24g/
day), and nutrition labelling (−0.16g/day). Tax andTable 3 Impact inventory and cost analysis of CVD-related model o
over the 20-year simulation period from 2013 to 2032 (US$ millions,
intervals
Outcome Men Wome
Change in total health-related costs 190 (48 to 440) 100 (23
Total medical costs to SUS 140 (36 to 330) 78 (17
Total informal care costs 46 (12 to 110) 25 (6 t
Total CHD-related costs 150 (38 to 350) 70 (14
CHD medical costs to SUS 120 (29 to 270) 54 (11
Informal care CHD costs 36 (9 to 84) 17 (3 t
Total stroke-related costs 38 (10 to 86) 33 (9 t
Stroke medical costs to SUS 28 (7 to 64) 25 (7 t
Informal care stroke costs 10 (3 to 22) 9 (2 tocommunity-based counselling could each typically re-
duce sodium intake by 0.12g/day, while even smaller
population benefits were derived from health education
media campaigns (−0.04g/day). Although long-term diet-
ary advice could achieve a −0.8g/day reduction under
optimal research trial conditions, smaller reductions
might be anticipated in unselected individuals [9]. Fur-
thermore, the burden of disease attributable to excessive
dietary sodium remains large, with almost 30,000 avoid-
able CHD and stroke deaths annually [6].
The voluntary targets reduced the average sodium
consumption by 0.1 g/day of sodium (0.25g/day salt) be-
tween 2013 and 2017 (a 25 mg/day reduction in sodium
every year), a reduction of just 2%. By contrast, the UK
achieved an average annual reduction of 80 mg/day
among men and 50 mg/day among women [14] between
2003 and 2010. However, in high-income countries such
as the UK, some 80% of dietary sodium comes from
processed and ultra-processed foods, compared with
only about 35% in Brazil, whereas over 55% comes from
added table salt [7, 20].
The Brazilian voluntary sodium targets have resulted
in a gradual sodium reduction to avoid noticeable
changes in the taste of foods and allow industries to
develop new technologies to reduce or replace sodiumutputs for individuals aged 30 to 79 years, assessed cumulatively
except when percentages). Brackets contain 95% uncertainty
n Persons As percentage of total costs
to 250) 290 (71 to 690) 0.094% (0.055 to 0.17%)
to 190) 220 (54 to 530) As above
o 61) 71 (17 to 170) As above
to 180) 220 (52 to 530) 0.072% (0.030 to 0.15%)
to 130) 170 (40 to 400) As above
o 42) 52 (12 to 130) As above
o 76) 72 (19 to 160) 0.14% (0.068 to 0.23%)
o 56) 53 (14 to 120) As above
20) 19 (5 to 42) As above
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compensatory behaviours as adding more table salt to
foods or while cooking [37, 38], while large reductions
in a short period may trigger rejection or compensatory
behaviour by consumers [39].
In 2018, the attributable costs of hypertension to the
Brazilian National Health System reached approximately
US$ 525 million/year [40], and in 2013, it was estimated
that some US$ 100 million/year in public hospitalisa-
tions could be saved if sodium consumption were re-
duced to 2 g/day in Brazil [41].
This study is focused solely on measuring industrial
sodium. This will become increasingly important given
the increasing contribution of ultra-processed foods in
diets. Food reformulation and other regulatory strategies
will, therefore, become essential for improving the food
environment by providing healthier food options [9].
Furthermore, reducing future population sodium in-
take in the Brazilian context will depend on strengthen-
ing industry action on sodium and improving strategies
to modify population behaviour concerning discretionary
(non-industrial) salt use. Thus, the Brazilian Dietary
Guidelines emphasise the importance of unprocessed
and minimally processed foods as the foundation of diets
and conscious use of culinary ingredients like salt.
Strengths and limitations of this study
The IMPACTNCD microsimulation framework has been
extensively validated and replicated in different countries
[13, 15]. This is the first IMPACT family microsimula-
tion model adapted to a Latin American country and
represents a big step forward for using models to inform
policy in the region. The study’s strengths also include
the use of representative population data and suitable ef-
fect sizes from meta-analyses.
This study also has potential limitations. First, the
model’s effect estimates are based on interventional and
prospective observational studies and may retain
possible biases and confounding factors. However, the
etiological effects of dietary changes were estimated
from meta-analyses with confirmatory validity analyses,
including from randomised clinical trials. Second, the es-
timated benefits from the model may be conservative
and underestimate the full health and economic health
gains from sodium reformulation, as (1) the counterfac-
tual scenario assumed that the participation of processed
and ultra-processed foods in sodium intake would not
change into the future; (2) the model only evaluated dis-
eases mediated through BP, while decreasing sodium
consumption could have beneficial effects upon other
health burdens such as gastric cancer [42]; (3) it was
assumed a median duration of 5 years from changes in
SBP to CVD risk; (4) only the first cardiovascular epi-
sode was considered. Therefore, only primary preventionbenefits were quantified; and (5) food reformulation by
industries might additionally increase potassium intake
through substitution of NaCl with KCl [43], which po-
tential beneficial effect was not included in the model.
Third, informal costs were based on evidence from
European countries and, therefore, might not represent
Brazil’s informal care costs. Finally, medical costs from
the private sector, which covers 30% of the Brazilian
population, were not included in the economic esti-
mates, which will therefore be conservative.
Conclusions
Our findings suggest that the voluntary sodium reduc-
tion targets for processed and ultra-processed foods in
Brazil could generate health benefits to the population
and cost savings to the National Health System and in-
formal health treatment cost. Nevertheless, to achieve
more substantial sodium reduction and its consequent
health and economic impacts, lower sodium targets
must be implemented across all food industries. Other
dietary sources of sodium must also be tackled, primarily
through food-based dietary guidelines and comprehen-
sive approaches to healthy diets. The potential health
and economic benefits could be substantial.
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